欧姆龙 (OTCMKTS:OMRNY) 股价下跌 0.1% - 你是否应该卖出？
Omron Corp. (OTCMKTS:OMRNY) shares fell 0.1% to $29.19, with a trading volume decline of 13%. The company reported Q2 earnings of $0.24 per share, exceeding estimates, but revenue of $1.29 billion fell short of expectations. Institutional investors hold 1.09% of the stock, with GAMMA Investing LLC increasing its stake by 180.8%. Analysts forecast a 0.42 EPS for the current fiscal year, and Omron holds a Hold rating among analysts, who suggest other stocks may be better investments.
Omron Corp. (OTCMKTS:OMRNY - Get Free Report)'s share price was down 0.1% on Monday . The stock traded as low as $29.13 and last traded at $29.19. Approximately 24,779 shares traded hands during trading, a decline of 13% from the average daily volume of 28,536 shares. The stock had previously closed at $29.23.
Omron Trading Down 0.1%
The firm has a market capitalization of $6.02 billion, a price-to-earnings ratio of 26.30, a PEG ratio of 0.41 and a beta of 1.10. The company has a fifty day moving average price of $27.37 and a two-hundred day moving average price of $27.19. The company has a current ratio of 2.34, a quick ratio of 1.54 and a debt-to-equity ratio of 0.13.
Omron (OTCMKTS:OMRNY - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.05. The business had revenue of $1.29 billion for the quarter, compared to analysts' expectations of $1.31 billion. Omron had a return on equity of 3.46% and a net margin of 4.04%. As a group, research analysts forecast that Omron Corp. will post 0.42 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its position in shares of Omron Corp. (OTCMKTS:OMRNY - Free Report) by 180.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,488 shares of the company's stock after buying an additional 958 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $40,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 1.09% of the company's stock.
About Omron
(Get Free Report)OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.
Read More
- Five stocks we like better than Omron
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Why Invest in 5G? How to Invest in 5G Stocks
- Does the Trump-Induced Quantum Stock Rally Have Legs?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Omron Right Now?
Before you consider Omron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.
While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
